We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
An integrated microfluidic pulmonary alveolus system for gradient-controlled investigation of nanoplastic-triggered lung inflammation and injury dynamics
Summary
Researchers developed an integrated lung-on-a-chip microfluidic system that generates precise concentration gradients of nanoparticles to study their effects on human alveolar barriers. They found that high-dose polystyrene nanoplastics caused clear toxicity to lung tissue models, while low doses triggered defensive inflammatory and antioxidant responses without significant damage. The platform offers a new tool for systematically evaluating dose-dependent respiratory risks from nanoplastic exposure.
Nanoplastics as emerging pollutants everywhere are suspected of potentially affecting human health. The lab-on-a-chip system facilitates the monitoring of external stimuli-induced biological events in vitro with microscale control. However, the establishment and application of multifunctional biomimetic organ-on-a-chip microsystem with physiological control for the efficient investigation of nanoplastic-induced biological responses in nanotoxicity exploration remains largely out of reach. Here, we propose an integrated microfluidic lung-on-a-chip system combining a nanoparticle gradient generator with multiple alveolar epithelial barrier models. The custom gradient generator allowed the sufficient mixing and linear concentration gradient production of nanoparticles. Subsystem integration and precise microfluidic control enabled multi-parallel and dynamic evaluation of the dose-dependent bioeffects of nanoparticles on in vitro recapitulated human alveolar barriers with organ-level responses at cellular- and molecular-scale resolutions. The clear nanotoxicity of high-dose polystyrene-nanoparticles (PS-NPs, over 50 μg/mL) was summarized based on the results of the inflammatory and injurious responses of the pulmonary alveoli. Low-dose PS-NPs significantly triggered the defense mechanism in the form of structural integrity, high viability, and the moderate up-regulation of antioxidant and proinflammatory activities. This approach offers insights into the potential toxicity risk of nanoplastics in humans. The integrated lung-on-a-chip system provides a proof-of-concept prototype for the efficient and biomimetic exploration of nanomedicine and environmental toxicology.
Sign in to start a discussion.
More Papers Like This
Development of Microfluidic, Serum-Free Bronchial Epithelial Cells-on-a-Chip to Facilitate a More Realistic In vitro Testing of Nanoplastics
A microfluidic bronchial epithelial cell-on-a-chip model was developed to test nanoplastic toxicity under dynamic flow conditions, with polystyrene nanoplastics found to reduce barrier integrity and trigger inflammatory signaling in a way not fully captured by conventional static cell culture systems.
Sentinel supervised lung-on-a-chip: A new environmental toxicology platform for nanoplastic-induced lung injury
Researchers built an advanced lung-on-a-chip device that mimics real lung tissue to study how inhaled nanoplastics cause lung injury. The study found that nanoplastics triggered inflammation and tissue damage patterns similar to chronic obstructive pulmonary disease. This new testing platform could help scientists better understand respiratory risks from airborne plastic particles without relying solely on animal studies.
In vitro evaluation of nanoplastics using human lung epithelial cells, microarray analysis and co-culture model
Researchers tested polystyrene nanoplastics on two types of human lung cells and found that the particles caused cell damage, oxidative stress, and inflammation-related gene changes at relatively low concentrations. Using a co-culture model that mimics the lung's layered structure, they showed that nanoplastics can trigger immune responses even in cells not directly exposed. The study suggests that inhaled nanoplastics may pose respiratory health risks through both direct toxicity and inflammatory signaling.
Unveiling the Pulmonary Toxicity of Polystyrene Nanoplastics: A Hierarchical Oxidative Stress Mechanism Driving Acute–Subacute Lung Injury
Researchers investigated the pulmonary toxicity of polystyrene nanoplastics smaller than 100 nm in lung epithelial cells and macrophages, finding that exposure triggered a hierarchical oxidative stress mechanism that drove acute to subacute lung injury through lipid peroxidation and inflammation.
Pulmonary hazards of nanoplastic particles: a study using polystyrene in in vitro models of the alveolar and bronchial epithelium
Lab tests on human lung cell models found that polystyrene nanoplastics did not cause immediate cell death but did interfere with key lung functions like surfactant and mucus production and immune signaling. This means standard toxicity tests may underestimate the real danger of inhaling nanoplastics, and researchers need to look beyond simple cell survival to understand the true health effects on the lungs.